Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546

Related Posts

Celebrating 20 years of excellence

The founding values of AiBST remain intact in our hearts. We equip scientists (both students and employees) with knowledge for generations to come.


Anniversary quote


We persist in becoming a pinnacle of strength of the biomedical field. Our journey has been filled with thrilling ups and downs  and we take pride in all the experiences we went through as they have created a history that cannot be re-written.

  1. Establishment of the African Institute of Biomedical Science and Technology

    The African Institute of Biomedical Science and Technology, AiBST, was established in 2002 to address a severe deficiency in Africa’s ability to contribute to finding healthcare solutions for the continent’s high disease burden. Given the multifaceted reasons for this underdevelopment in biomedical research which include poor infrastructure, poor economies, political instability and limited skilled human resources, AiBST had to be established on a unique hybrid strategy that could simultaneously address some of these issues with the ultimate goal of delivering efficacious, safe and affordable healthcare products and services in Africa.

  2. AiBST as a virtual institute

    From 2002 to 2004, AiBST operated as a virtual institute. It operated by organising international courses on the science and technologies of drug discovery and developed where leading international scientists from academia and industry went to share their knowledge with their African counter parts. The first course was in Cape Town (South Africa) in 2002 and focused on ADMET for drug discovery. The second one was in Nairobi (Kenya) in 2003 focusing on Pharmacogenetics of Drug Metabolism. The courses generated tremendous interest among African scientists resulting in them forming the African Society for Drug Metabolism and Development (ASDMD) at the meeting in Cape Town and the African Consortium for Biobanking and Pharmacogenetics Databasing at the meeting in Nairobi.

  3. AiBST official opening

    The AiBST biomedical laboratory was officially opened in 2005 by the Minster of Science and Technology Development (MSTD). AiBST experienced rapid growth and recognition in Africa and internationally. In Africa, major institutions like the University of Cape Town (South Africa), University of Nairobi (Kenya), Obafemi Awolowo University (Nigeria) quickly realised the phenomenal potential AiBST had to establish pharmaceutical R&D in Africa and signed memorandums of understanding (MOUs) for collaboration in biomedical education and research. In line with its continental agenda, AiBST established satellite laboratories, one at the University of Cape Town and another at the University of Nairobi

  4. Registration with the Ministry of Higher and tertiary education

    With a clear focus on postgraduate education to increase skilled manpower to champion biomedical research, AiBST was registered with the Ministry of Higher and tertiary Education in 2008. The emerging track record of high quality research in its flagship competence in DMPK & Bioanalytical Chemistry and in Pharmacogenomics, led to AiBST being made a DMPK Centre of Excellence (CoE) by WHO-TDR

  5. More recognition and exponential growth

    AiBST was became an African Network for Drugs and Diagnostics Innovation CoE in DMPK and Toxicology in 2010. International institutions, including Karolinska Institute, Riken Institute and Stanford University also identified AiBST is a research collaborator of choice in conducting high quality research. Major funding organisations such as WHO-TDR, CDC (USA), EU, ISP and TWAS also came on board to support AiBST’s research and educational activities.

  6. A decade of phenomenal development

    The year 2011 marked a decade of phenomenal development of an initiative which held the promise of pharmaceutical R&D in Africa that enabled African scientists to contribute in the discovery of biomedical solutions to the continent’s healthcare challenges. 

  7. The beginning of Paternity testing

    The end of 2013 into 2014 marked the beginning of paternity testing.